Showing 1 - 9 results of 9 for search 'Maio, M', query time: 0.04s
Refine Results
-
1
Learning the hard way: the effect of violent conflict on student academic achievement by Brück, T, Di Maio, M, Miaari, S
Published 2019Journal article -
2
-
3
„Zwischenmenschlichkeit ist die Grundbedingung für gute Medizin“ by Prof. Dr. med. Giovanni Maio M. A. phil., Peter Stegmaier
Published 2023-04-01
Article -
4
HEALTH-CARE RESOURCE UTILIZATION IN ADVANCED MELANOMA: AN ANALYSIS FROM THE MELODY OBSERVATIONAL STUDY by Lorigan, P, Maio, M, Middleton, M, Testori, A, Bedane, C, van Baardewijk, M, Konto, C, Dueymes, A, Lebbe, C
Published 2010Journal article -
5
Treatment patterns and outcomes among patients diagnosed with unresectable stage III or IV melanoma in Europe: A retrospective, longitudinal survey (MELODY study) by Lebbe, C, Lorigan, P, Ascierto, P, Testori, A, Bédane, C, Middleton, M, Van Baardewijk, M, Konto, C, Dueymes, A, Maio, M
Published 2012Journal article -
6
Treatment patterns and outcomes among patients diagnosed with unresectable stage III or IV melanoma in Europe: a retrospective, longitudinal survey (MELODY study). by Lebbe, C, Lorigan, P, Ascierto, P, Testori, A, Bédane, C, Middleton, M, van Baardewijk, M, Konto, C, Dueymes, A, Maio, M
Published 2012Journal article -
7
Economic impact of healthcare resource utilisation patterns among patients diagnosed with advanced melanoma in the United Kingdom, Italy, and France: results from a retrospective,... by Johnston, K, Levy, A, Lorigan, P, Maio, M, Lebbe, C, Middleton, M, Testori, A, Bédane, C, Konto, C, Dueymes, A, Sbarigia, U, van Baardewijk, M
Published 2012Journal article -
8
Economic impact of healthcare resource utilisation patterns among patients diagnosed with advanced melanoma in the United Kingdom, Italy, and France: results from a retrospective,... by Johnston, K, Levy, A, Lorigan, P, Maio, M, Lebbe, C, Middleton, M, Testori, A, Bédane, C, Konto, C, Dueymes, A, Sbarigia, U, van Baardewijk, M
Published 2012Journal article -
9
Adjuvant nivolumab (NIVO) versus ipilimumab (IPI) in resected stage III/IV melanoma: 3-year efficacy and biomarker results from the phase III CheckMate 238 trial by Weber, J, Del Vecchio, M, Mandala, M, Gogas, H, Arance, A, Dalle, S, Cowey, C, Schenker, M, Grob, J, Chiarion-Sileni, V, Marquez-Rodas, I, Butler, M, Maio, M, Middleton, M, Tang, T, Saci, A, De Pril, V, Lobo, M, Larkin, J, Ascierto, P
Published 2019Conference item